Trial · NCT01436162
Results by group46
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 46
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Mean Change From Baseline in Montgomery-Asberg Depression Rating Scale (MADRS) Total Score at 8 Weeks | Antidepressant + SPD489 | -7.3 | 95% Confidence Interval -8.6 to -6.0 | units on a scale | |
| Mean Change From Baseline in Montgomery-Asberg Depression Rating Scale (MADRS) Total Score at 8 Weeks | Antidepressant + Placebo | -6.8 | 95% Confidence Interval -8.1 to -5.5 | units on a scale | |
| Mean Change From Baseline in Sheehan Disability Scale (SDS) Total Score at 8 Weeks | Antidepressant + SPD489 | -4.9 | 95% Confidence Interval -5.8 to -4.0 | units on a scale | |
| Mean Change From Baseline in Sheehan Disability Scale (SDS) Total Score at 8 Weeks | Antidepressant + Placebo | -4.3 | 95% Confidence Interval -5.2 to -3.4 | units on a scale | |
| Percentage of Participants Achieving a 25% Response on the MADRS | Antidepressant + SPD489 | 68.9 | percentage of participants | ||
| Percentage of Participants Achieving a 25% Response on the MADRS | Antidepressant + Placebo | 74.2 | percentage of participants | ||
| Percentage of Participants Achieving a 50% Response on the MADRS | Antidepressant + SPD489 | 41.6 | percentage of participants | ||
| Percentage of Participants Achieving a 50% Response on the MADRS | Antidepressant + Placebo | 37.1 | percentage of participants | ||
| Percent of Participants Achieving Remission on the MADRS | Antidepressant + SPD489 | 23.0 | percentage of participants | ||
| Percent of Participants Achieving Remission on the MADRS | Antidepressant + Placebo | 17.8 | percentage of participants | ||
| Mean Change From Baseline Over Time in MADRS Total Score | Antidepressant + SPD489 | Week 9 (Visit 9) | -2.9 | 95% Confidence Interval -3.9 to -2.0 | units on a scale |
| Mean Change From Baseline Over Time in MADRS Total Score | Antidepressant + Placebo | Week 9 (Visit 9) | -2.1 | 95% Confidence Interval -3.0 to -1.1 | units on a scale |
| Mean Change From Baseline Over Time in MADRS Total Score | Antidepressant + SPD489 | Week 10 (Visit 10) | -4.4 | 95% Confidence Interval -5.5 to -3.3 | units on a scale |
| Mean Change From Baseline Over Time in MADRS Total Score | Antidepressant + Placebo | Week 10 (Visit 10) | -4.3 | 95% Confidence Interval -5.4 to -3.2 | units on a scale |
| Mean Change From Baseline Over Time in MADRS Total Score | Antidepressant + SPD489 | Week 11 (Visit 11) | -5.9 | 95% Confidence Interval -7.1 to -4.7 | units on a scale |
| Mean Change From Baseline Over Time in MADRS Total Score | Antidepressant + Placebo | Week 11 (Visit 11) | -5.0 | 95% Confidence Interval -6.2 to -3.8 | units on a scale |
| Mean Change From Baseline Over Time in MADRS Total Score | Antidepressant + SPD489 | Week 12 (Visit 12) | -6.3 | 95% Confidence Interval -7.6 to -5.1 | units on a scale |
| Mean Change From Baseline Over Time in MADRS Total Score | Antidepressant + Placebo | Week 12 (Visit 12) | -5.3 | 95% Confidence Interval -6.5 to -4.1 | units on a scale |
| Mean Change From Baseline Over Time in MADRS Total Score | Antidepressant + SPD489 | Week 14 (Visit 13) | -6.9 | 95% Confidence Interval -8.2 to -5.5 | units on a scale |
| Mean Change From Baseline Over Time in MADRS Total Score | Antidepressant + Placebo | Week 14 (Visit 13) | -6.4 | 95% Confidence Interval -7.7 to -5.1 | units on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01436162/results